SomaFocus, or Equal 3D multi-electrode array (MEA) System plus four (4) option years of Preventive Maintenance and unlimited repairs
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FDA OFFICE OF ACQ GRANT SVCS
Contract Value
Not provided
Codes & Classification
Solicitation Number
75F40126Q135970
NAICS
334516 - Analytical Laboratory Instrument Manufacturing
Classification Code
6640
Additional Details
Documents2
The Food and Drug Administration (FDA), operating under the Department of Health and Human Services, has issued a combined synopsis/solicitation for the procurement of a SomaFocus, or equal, 3D multi-electrode array (MEA) system. This opportunity, identified by procurement number 75F40126Q135970, is classified under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) and product service code 6640, indicating its focus on advanced laboratory instrumentation.
The primary objective of this procurement is to acquire a state-of-the-art 3D MEA system, which is essential for analytical and research applications within the FDA. The scope of the contract extends beyond the initial equipment purchase, encompassing four (4) option years of preventive maintenance and unlimited repairs. This comprehensive support ensures the sustained operational integrity and reliability of the MEA system throughout its lifecycle, minimizing downtime and maximizing research productivity.
The solicitation specifies that offers for "SomaFocus, or equal" systems are acceptable, allowing for equivalent solutions that meet the FDA’s technical and performance requirements. Contractors are expected to provide not only the equipment but also ongoing maintenance and repair services, demonstrating their capability to support the FDA’s long-term needs.
This procurement is set aside for Small Business Administration (SBA) eligible entities, reflecting the FDA’s commitment to engaging small businesses in federal contracting. Interested parties should ensure they meet the SBA set-aside criteria before submitting a response.
The contracting entity is the FDA Office of Acquisition and Grant Services, a federal office responsible for managing procurement activities. The primary point of contact for this opportunity is Suzanne Martella, who can be reached via email at [email protected] or by phone at 301-796-2383. Additional information, including solicitation documents and attachments, is available through the official SAM.gov listing at https://sam.gov/opp/59812e25668049d0bddc69e6f25f1c69/view.
The solicitation was most recently updated on August 28, 2026, to correct the contract duration in clause 52.217-9, confirming a total contract period of five (5) years to cover all post-warranty maintenance option periods. The notice remains active, with a response deadline set for September 3, 2026.
Contractors evaluating this opportunity should consider their ability to deliver high-quality laboratory instrumentation, provide reliable preventive maintenance and repair services over an extended period, and comply with SBA set-aside requirements. The FDA seeks a partner capable of supporting its mission-critical research infrastructure with robust, responsive service and technical expertise.